SG69981A1 - Treatment of cellulite with retinoids - Google Patents

Treatment of cellulite with retinoids

Info

Publication number
SG69981A1
SG69981A1 SG1996008319A SG1996008319A SG69981A1 SG 69981 A1 SG69981 A1 SG 69981A1 SG 1996008319 A SG1996008319 A SG 1996008319A SG 1996008319 A SG1996008319 A SG 1996008319A SG 69981 A1 SG69981 A1 SG 69981A1
Authority
SG
Singapore
Prior art keywords
cellulite
retinoids
treatment
amount
retinoid
Prior art date
Application number
SG1996008319A
Other languages
English (en)
Inventor
Albert M Kligman
Original Assignee
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert M Kligman filed Critical Albert M Kligman
Publication of SG69981A1 publication Critical patent/SG69981A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SG1996008319A 1991-02-27 1992-02-26 Treatment of cellulite with retinoids SG69981A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/661,753 US5051449A (en) 1991-02-27 1991-02-27 Treatment of cellulite with retinoids

Publications (1)

Publication Number Publication Date
SG69981A1 true SG69981A1 (en) 2000-01-25

Family

ID=24654977

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008319A SG69981A1 (en) 1991-02-27 1992-02-26 Treatment of cellulite with retinoids

Country Status (17)

Country Link
US (1) US5051449A (fr)
EP (1) EP0573601B1 (fr)
JP (1) JP2893483B2 (fr)
KR (1) KR100224284B1 (fr)
AT (1) ATE172113T1 (fr)
AU (1) AU666303B2 (fr)
CA (1) CA2104452C (fr)
DE (1) DE69227306T2 (fr)
DK (1) DK0573601T3 (fr)
ES (1) ES2124725T3 (fr)
FI (1) FI103950B (fr)
HU (1) HU218914B (fr)
IE (1) IE920624A1 (fr)
NO (1) NO304727B1 (fr)
NZ (1) NZ241757A (fr)
SG (1) SG69981A1 (fr)
WO (1) WO1992015293A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
US5521221A (en) * 1991-04-09 1996-05-28 Sloan-Kettering Institute For Cancer Research Retro-α-retinol (4,14-retro-retinol) derivatives and uses of retro-α-retinol
JP2765354B2 (ja) * 1992-03-09 1998-06-11 住友電装株式会社 接続具における電線の敷線方法
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
WO1997014412A1 (fr) * 1994-08-26 1997-04-24 Mary Kay Inc. Traitements structurels de la cellulite, par applications locales
US5587396A (en) * 1994-08-26 1996-12-24 Mary Kay Inc. Method of ameliorating cellulite by disrupting the barrier function of the stratum corneum
US5529769A (en) * 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
ATE247463T1 (de) * 1995-10-18 2003-09-15 Mary Kay Inc Topisch angewandte strukturelle behandlungen der zellulitis
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US6008254A (en) 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
CA2529953A1 (fr) * 2003-06-23 2004-12-29 Transpharma Medical Ltd. Systeme d'administration transdermique d'agents cosmetiques
FR2863492B1 (fr) * 2003-12-10 2007-08-24 Oreal Utilisation des modulateurs d'aquaglyceroporines comme amincissant
DE102004002606A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut
WO2007016050A1 (fr) * 2005-07-28 2007-02-08 Global Cosmeceutical Innovations, Llc Composition et methode de traitement de la cellulite
US20090209637A1 (en) * 2006-08-30 2009-08-20 Christophe Carola Use of chromen-4-one derivatives
EP1977743B1 (fr) 2007-03-20 2009-09-02 Johnson & Johnson Consumer France SAS Compositions contenant un retinoide et des dèrivés de l'acide beta-aminoisobutyrique
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
DE102010054149A1 (de) 2010-12-10 2012-06-14 Merck Patent Gmbh 2-Pyrone
EP3368009A1 (fr) 2015-10-30 2018-09-05 Patagonia Pharmaceuticals, LLC Formulations d'isotrétinoïne, leurs utilisations et méthodes associées

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4288633A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
MY106263A (en) * 1989-01-19 1995-04-29 Ortho Pharma Corp Method for the treatment or prevention of intrinsically aged skin with retinoids
US5070108A (en) * 1990-10-12 1991-12-03 Trustees Of The University Of Pennsylvania Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
MX9201084A (es) * 1991-04-15 1992-12-21 Bristol Myers Squibb Co Hiper pigmentacion de la piel

Also Published As

Publication number Publication date
AU666303B2 (en) 1996-02-08
HUT65651A (en) 1994-07-28
WO1992015293A1 (fr) 1992-09-17
CA2104452C (fr) 2002-07-16
HU9302437D0 (en) 1993-11-29
IE920624A1 (en) 1992-09-09
NO304727B1 (no) 1999-02-08
NZ241757A (en) 1994-04-27
AU1644892A (en) 1992-10-06
ES2124725T3 (es) 1999-02-16
HU218914B (hu) 2000-12-28
JP2893483B2 (ja) 1999-05-24
DK0573601T3 (da) 1999-06-23
FI933736A (fi) 1993-08-25
KR100224284B1 (ko) 1999-10-15
FI103950B1 (fi) 1999-10-29
FI933736A0 (fi) 1993-08-25
ATE172113T1 (de) 1998-10-15
DE69227306T2 (de) 1999-06-02
EP0573601B1 (fr) 1998-10-14
CA2104452A1 (fr) 1992-08-28
EP0573601A4 (fr) 1994-01-12
JPH06507395A (ja) 1994-08-25
KR930702992A (ko) 1993-11-29
FI103950B (fi) 1999-10-29
DE69227306D1 (de) 1998-11-19
EP0573601A1 (fr) 1993-12-15
NO932949L (no) 1993-08-19
NO932949D0 (no) 1993-08-19
US5051449A (en) 1991-09-24

Similar Documents

Publication Publication Date Title
SG69981A1 (en) Treatment of cellulite with retinoids
CA2145541A1 (fr) Composition cosmetique renfermant du retinol
DE69210515D1 (de) Kosmetisches Mittel
DE69029804D1 (de) VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
CA2144509A1 (fr) Composition pour le conditionnement de la peau; methode de preparation et application
DE59410301D1 (de) Topische zubereitungen mit einem gehalt an l-arginin
EP0342056A3 (en) Cosmetic composition
EP0803248A3 (fr) Compositions pour les soins de la peau contenant rétinol ou rétinyl ester
CA2099188A1 (fr) Utilisation d'une composition cosmetique
CA2202339A1 (fr) Compositions pour soins de la peau, a base de melinamide et d'un retinoide
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
AU5132799A (en) Short contact treatment of acne and photoaging with topical retinoids
NO920805D0 (no) Metoder for forhindring og redusering av stoerrelsen av striae distensae-lesjoner
IE873478L (en) Use of 13-cis retinoic acid
ZA971405B (en) Skin treatment with salicylic acid esters and retinoids
AU3802289A (en) Treatment of periodontoclasia with retinoic acid
DE69018570D1 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
MX9703471A (es) Composicion cosmetica con esteres de acido graso retinol insaturado de cadena larga.
TH15130EX (th) ส่วนประกอบของเครื่องสำอางที่ใช้กับผิวหนังที่ก่อ ให้เกิดการระคายเคืองต่ำสำหรับใช้เฉพาะแห่งเป็น ประจำทุกวัน, การนำไปใช้และการผลิต
GR890100035A (en) Method for preparation of a means that contains salicyloxyd against scaling sick